MedTrace Logo

A Comparative Study of Azithromycin and S-P as Prophylaxis in Pregnant HIV+ Patients

NCT02527005 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 140

Last updated 2017-12-11

No results posted yet for this study

Summary

Randomized controlled single blind prospective comparative study

Conditions

Interventions

DRUG

Sulphadoxine-pyrimethamine

Sulphadoxine-Pyrimethamine 500mg of Sulphadoxine and 25mg of Pyrimethamine 3tablets monthly for 3 doses

DRUG

Azithromycin

Tabs Azithromycin 500mg daily for 3 days

Sponsors & Collaborators

  • University of Ibadan

    lead OTHER

Principal Investigators

  • AYODELE O AROWOJOLU, MBBS IBADAN · UNIVERSITY COLLEGE HOSPITAL,IBADAN,OYO STATE, NIGERIA

  • ORIYOMI O AKINYOTU, MBBS IBADAN · UNIVERSITY COLLEGE HOSPITAL, IBADAN, OYO STATE, NIGERIA

  • ADENIKE F BELLO, MBBS IBADAN · UNIVERSITY COLLEGE HOSPITAL, IBADAN, OYO STATE, NIGERIA

  • ADEOLA R ABDUS-SALAM, MBBS IBADAN · ADEOYO MATERNITY TEACHING HOSPITAL, IBADAN, OYO STATE

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-09-30
Primary Completion
2016-08-31
Completion
2016-08-31

Countries

  • Nigeria

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02527005 on ClinicalTrials.gov